patents Archives - World Asthma Foundation

May 28, 2014

Patents for new method to rid carpets and mattresses to reduce asthma – News-Medical.net

Patents for new method to rid carpets and mattresses to reduce asthma
News-Medical.net
A team of researchers from the University of South Carolina received two patents for a new method to rid carpets, mattresses and other furniture of harmful allergens and pests that cause asthma. The patents (Methods and Compositions for Eliminating …
Patents granted for CO2-based allergen removal techniqueHealio

all 3 news articles »

View full post on asthma – Google News

September 9, 2012

Teva sues Perrigo over ProAir asthma inhaler patents – Globes

Teva sues Perrigo over ProAir asthma inhaler patents
Globes
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) unit Teva Branded Pharmaceutical Products R&D Inc. has filed patent infringement suit with the US District Court for the District of Delaware against Perrigo Company (Nasdaq:PRGO; …

View full post on asthma – Google News

September 6, 2012

Teva Sues Perrigo Over Patents for Proair Asthma Inhaler – Bloomberg

Teva Sues Perrigo Over Patents for Proair Asthma Inhaler
Bloomberg
(PRGO) over patents for the ProAir asthma inhaler. Teva Branded Pharmaceutical Products R&D Inc. of Horsham, Pennsylvania, contends Allegan, Michigan-based Perrigo is planning to market its version of the albuterol sulfate aerosol inhaler before the …

View full post on asthma – Google News

August 6, 2010

CORRECT: Vectura Licenses Patents To GlaxoSmithKline – Wall Street Journal

Stockopedia

CORRECT: Vectura Licenses Patents To GlaxoSmithKline
Wall Street Journal
VX) generics unit Sandoz handed back the US rights to VR315, a generic version of an asthma drug, to Vectura. Analysts said it signaled Sandoz wasn't sure …
INTERVIEW: Vectura Patents For GSK's 573719 And 642444Wall Street Journal
Vectura and GlaxoSmithKline sign agreement over asthma patentsStockopedia
Vectura boosted by deal with GSK worth over $30 million upfront plus royalties …The Pharma Letter (subscription)

all 23 news articles »

View full post on asthma – Google News

July 15, 2010

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, “5-Lipoxygenase Activating Protein (FLAP) Inhibitors,” which includes coverage of Amira’s AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.